Ronald Bosch

Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding during Suppressive Antiretroviral Therapy.

Hastie E, Moser C, Sun X, Lennox J, Hsue PY, Bosch RJ, Deeks S, Meneses MV, Lederman MM, Hunt P, Henrich TJ, Marconi VC, Gianella S.

J Infect Dis. 2023 Mar 07. PMID: 36881933

HIV post-treatment controllers have distinct immunological and virological features.

Etemad B, Sun X, Li Y, Melberg M, Moisi D, Gottlieb R, Ahmed H, Aga E, Bosch RJ, Acosta EP, Yuki Y, Martin MP, Carrington M, Gandhi RT, Jacobson JM, Volberding P, Connick E, Mitsuyasu R, Frank I, Saag M, Eron JJ, Skiest D, Margolis DM, Havlir D, Schooley RT, Lederman MM, Yu XG, Li JZ.

Proc Natl Acad Sci U S A. 2023 Mar 14. 120(11):e2218960120. PMID: 36877848

Varied Patterns of Decay of Intact HIV-1 Proviruses Over two Decades of Art.

Gandhi RT, Bosch RJ, Mar H, Laird GM, Halvas EK, Hovind L, Collier AC, Riddler SA, Martin A, Ritter K, McMahon DK, Eron JJ, Cyktor JC, Mellors JW.

J Infect Dis. 2023 Feb 10. PMID: 36763044

Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy.

Lian X, Seiger KW, Parsons EM, Gao C, Sun W, Gladkov GT, Roseto IC, Einkauf KB, Osborn MR, Chevalier JM, Jiang C, Blackmer J, Carrington M, Rosenberg ES, Lederman MM, McMahon DK, Bosch RJ, Jacobson JM, Gandhi RT, Peluso MJ, Chun TW, Deeks SG, Yu XG, Lichterfeld M.

Cell Host Microbe. 2023 01 11. 31(1):83-96.e5. PMID: 36596305

Evaluating the effect of atorvastatin exposure and vitamin D levels on lipid outcomes in people with HIV-1 with suppressed HIV-1 RNA and LDL cholesterol <130?mg/dL.

Rahman F, Brates I, Aweeka F, Bosch RJ, Deitchman A, Nixon D, Aberg JA.

HIV Med. 2022 Dec 22. PMID: 36549898

Comparative sensitivity of automated (Abbott M2000) and manual plasma HIV-1 RNA PCR assays for the detection of persistent viremia after long-term antiretroviral therapy.

Tosiano MA, Mar H, Hoeth D, Eron JJ, Gandhi RT, McMahon DK, Bosch RJ, Mellors JW, Cyktor JC.

J Virus Erad. 2022 Dec. 8(4):100095. PMID: 36479541

The changing prevalence of anemia and risk factors in people with HIV in North America who have initiated ART, 2007-2017.

Lang R, Gill MJ, Coburn SB, Grossman J, Gebo KA, Horberg MA, Mayor AM, Silverberg MJ, Willig AL, Justice AC, Klein MB, Bosch RJ, Rabkin CS, Hogan B, Thorne JE, Moore RD, Althoff KN.

AIDS. 2023 02 01. 37(2):287-298. PMID: 36541641

Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial.

Scully EP, Aga E, Tsibris A, Archin N, Starr K, Ma Q, Morse GD, Squires KE, Howell BJ, Wu G, Hosey L, Sieg SF, Ehui L, Giguel F, Coxen K, Dobrowolski C, Gandhi M, Deeks S, Chomont N, Connick E, Godfrey C, Karn J, Kuritzkes DR, Bosch RJ, Gandhi RT.

Clin Infect Dis. 2022 10 12. 75(8):1389-1396. PMID: 35176755

Evaluating the Cardiovascular Risk in an Aging Population of People With HIV: The Impact of Hepatitis C Virus Coinfection.

Lang R, Humes E, Hogan B, Lee J, D'Agostino R, Massaro J, Kim A, Meigs JB, Borowsky L, He W, Lyass A, Cheng D, Kim HN, Klein MB, Cachay ER, Bosch RJ, Gill MJ, Silverberg MJ, Thorne JE, McGinnis K, Horberg MA, Sterling TR, Triant VA, Althoff KN.

J Am Heart Assoc. 2022 10 04. 11(19):e026473. PMID: 36129038

Toward Ending the HIV Epidemic: Temporal Trends and Disparities in Early ART Initiation and Early Viral Suppression Among People Newly Entering HIV Care in the United States, 2012-2018.

Li J, Humes E, Lee JS, Althoff KN, Colasanti JA, Bosch RJ, Horberg M, Rebeiro PF, Silverberg MJ, Nijhawan AE, Parcesepe A, Gill J, Shah S, Crane H, Moore R, Lang R, Thorne J, Sterling T, Hanna DB, Buchacz K.

Open Forum Infect Dis. 2022 Aug. 9(8):ofac336. PMID: 35937648